Dr. Kimberly Lee | Chief Corporate Affairs Officer |
RA Session | President, Founder, and Chief Executive Officer |
Dr. Suyash Prasad | Chief Medical Officer and Head, R&D |
Kamran Alam | Chief Financial Officer |
Dr. Frederick Porter | Chief Technical Officer |
Joon Lee | Jo Securities |
Gil Blum | Needham & Company |
Mike Ulz | Morgan Stanley |
Eun Yang | Jefferies |
Jack Allen | Baird |
Yun Zhong | BTIG |
Sami Corwin | William Blair |
Rick Miller | Cantor Fitzgerald |
Greetings. Welcome to the Taysha Gene Therapies Second Quarter 2022 Financial Results and Corporate Update Conference Call. At this time, all participants are in listen-only mode.
Following management's prepared remarks, we will hold a brief question-and-answer session.
As a reminder, this call is being recorded today, August 11, 2022.